These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28927711)

  • 21. Efficacy, tolerability, and blood concentration of zonisamide in daily clinical practice.
    Park KM; Lee BI; Shin KJ; Ha SY; Park J; Kim SE; Kim SE
    J Clin Neurosci; 2019 Mar; 61():44-47. PubMed ID: 30446366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life in patients with partial-onset seizures under adjunctive therapy with zonisamide: results from a prospective non-interventional surveillance study.
    Helmstaedter C; Stefan H; Witt JA
    Epileptic Disord; 2011 Sep; 13(3):263-76. PubMed ID: 21914589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy.
    Mandelbaum DE; Bunch M; Kugler SL; Venkatasubramanian A; Wollack JB
    J Child Neurol; 2005 Jul; 20(7):594-7. PubMed ID: 16159527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zonisamide for refractory juvenile absence epilepsy.
    Velizarova R; Crespel A; Genton P; Serafini A; Gelisse P
    Epilepsy Res; 2014 Sep; 108(7):1263-6. PubMed ID: 24907183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability of lacosamide or zonisamide in elderly patients with seizures.
    Sarkis RA; Nicolas J; Lee JW
    Seizure; 2017 Jul; 49():1-4. PubMed ID: 28486158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy.
    Eun SH; Kim HD; Eun BL; Lee IK; Chung HJ; Kim JS; Kang HC; Lee YM; Suh ES; Kim DW; Eom S; Lee JS; Moon HK
    Seizure; 2011 Sep; 20(7):558-63. PubMed ID: 21543239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and monitoring of patients treated with zonisamide: the OZONE study.
    Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B
    Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial.
    Guerrini R; Rosati A; Bradshaw K; Giorgi L
    Epilepsia; 2014 Apr; 55(4):568-78. PubMed ID: 24621319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
    Wellmer J; Wellmer S; Bauer J
    Acta Neurol Scand; 2009 Apr; 119(4):233-8. PubMed ID: 19053955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study.
    Romigi A; Izzi F; Placidi F; Zannino S; Evangelista E; Del Bianco C; Copetti M; Vitrani G; Mercuri NB; Cum F; Marciani MG
    Epilepsy Behav; 2013 Feb; 26(2):170-4. PubMed ID: 23312598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults.
    Mula M
    Drug Des Devel Ther; 2013; 7():397-402. PubMed ID: 23700365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zonisamide as adjunctive therapy for refractory partial seizures.
    Brodie MJ
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zonisamide in the management of epilepsy in the elderly.
    Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V
    Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.